As he walked, Zheng Ren saw a plainly dressed, or rather disheveled, middle-aged man standing outside a ward with a blank look on his face, his eyes slightly red, as if he was crying.
His clothes and temperament were incompatible with Buta Private Hospital.
Zheng Ren knew from his clothes that he was a family member of a volunteer. An experiment must have failed, and his relatives were facing death. Maybe he is dead, maybe he will die soon, it doesn't matter.
Sighing slightly, Su Yun asked: "Mr. Johannes Mandy, are the relatives of the patient's family working as volunteers?"
"Yes, Dr. Su. A patient with advanced lung cancer. We wanted to find a patient with advanced stage to test a new drug. Unfortunately, it was too late for him," said Johannes Mandy.
Zheng Ren narrowed his eyes. Johannes Mandy did not explain the progress of their project, but the simple sentence just now did not contain too much meaning.
Does finding patients at a more advanced stage for testing mean that patients at an earlier stage already have a more certain treatment method
possible!
In fact, the moment Zheng Ren knew about the emergence of DeepMACT, he knew that things that were impossible before were beginning to become possible.
DeepMACT can play a crucial role in the effect of targeted drugs on tumor tissues or cells. It can be observed almost in real time, and if the effect is not good, the drug concentration or effect can be adjusted.
Unexpectedly, the drug research in Bota's laboratory has made breakthrough progress, and now they have even begun to treat patients with advanced tumors.
"Mr. Johannes Mandy, is the patient in a bad condition and unable to bear the side effects of the medicine?" Zheng Ren asked.
"No, Dr. Zheng." Johannes Mandy said: "As far as I know, the patient's chest CT scan and reconstruction showed total visceral inversion, an intraluminal mass in the middle of the trachea, about 3cm long, and the lumen was obviously narrow. The obstacles are obvious. What we need is patients with this condition, and the patients themselves still have some hope for this trial."
"On the second day of admission, the patient's dyspnea at night further worsened and he could not lie down. He was given 8L/min oxygen through a mask and maintained SaO2 at around 80% to 85%. It seemed a little too late for the poor guy. I have read relevant examine… "
"What happened next?" Zheng Ren didn't want to hear anything else from Johannes Mandy. The focus of his eyes was always on the patient.
"Later, the patient was moved to a semi-recumbent position, and oxygen was inhaled through an oxygen storage mask. After symptomatic treatment with intravenous injection of methylprednisolone, the dyspnea was relieved, and the Sa02 remained at around 93%."
"On the third day of admission, I tried to perform bronchoscopy in a semi-recumbent position under local anesthesia with 2% lidocaine. When the bronchoscope was about to enter the glottis, the patient had difficulty breathing and could not tolerate it." Johannes Mandy sighed. Said: "Then there is nothing we can do. If the airway stent cannot be inserted..."
As he spoke, he shrugged and made a helpless expression.
"At the very least, you have to ensure breathing before you can proceed to the next step of the test. The poor guy can't even do the first step. Damn the recruiter, I want patients with terminal cancer, not just to come to Betta." Dead people! Dead people can't use new drugs, and all the previous work was in vain! Those idiots!" Johannes Mandy said angrily.
Zheng Ren recalled what Johannes Mandy said before. A few seconds later, he said in a deep voice: "Has the genetic test been completed? How about the evaluation of related drugs?"
Johannes Mandy was a little hesitant when he heard Zheng Ren ask this.
"The boss is only interested in the patient's condition, not your skills." Su Yun said coldly: "I believe Christian has already told you about this."
When he mentioned Christian, Zheng Ren felt that there was some change in the aura of Johannes Mandy.
"That's right, Doctor Zheng, Doctor Su." Johannes Mandy said quickly, "The gene sequencing and corresponding work can only be completed in 24 hours. This is already the fastest speed. But the patient will never survive 24 hours. Hours, even if it’s…”
Zheng Ren knew that the so-called medicine would not be the kind that would heal immediately after taking it, but after all, it was a hope.
As long as there is a thought and a faint glimmer of hope, even if it is so weak that the light can hardly be seen, if there are enough, it can support a raging fire and light up the sky.
"Mr. Johannes Mandy, I would like to see the patient's relevant information." Zheng Ren said solemnly, "Maybe I can find a way to solve the patient's difficulty in breathing."
"Oh, no! That's impossible!" Johannes Mandy said subconsciously: "We can't even intubate the trachea. The patient's condition is too serious. It was a mistake for him to appear in Botta. Now we have to It’s about correcting that mistake.”
Zheng Ren frowned and glanced at Johannes Mandy. Mandy felt that he had said too much, so he immediately smiled, trying to ease the awkward atmosphere.
"Boss, what do you want to do?" Su Yun asked in Mandarin.
“In recent years, transbronchoscopic stent placement has been increasingly used to relieve airway stenosis. Due to its high safety, simple operation, quick onset of effect, and few postoperative complications, it has now become a popular method for relieving airway stenosis. One of the preferred treatment methods." Zheng Ren said to Su Yun while thinking.
Su Yun knew that his boss said some seemingly meaningless words first, and knew that he was sorting out his thoughts.
Things that Bota Private Hospital can't do must be extremely difficult. Even if the boss has some ideas, he may not be perfect.
"However, the choice of anesthesia and ventilation methods during bronchoscopy interventional treatment limits the treatment of some patients with severe airway stenosis. For patients with severe airway obstruction, there are certain risks during the operation, and may even cause the patient's heart and respiratory arrest." Zheng Ren continued to speak in a deep voice.
There seemed to be no change in the speed of his speech, neither fast nor slow.
"The mass in the middle of the patient's trachea blocks the lumen, and the difficulty in breathing cannot be solved through tracheotomy or intubation. It seems that treatment can be given up. If I encounter a similar patient in 912, I will think that even if I die from the disease, I will not suffocate to death."
"Boss, do you have any idea?" Su Yun asked.
"Hypoxia is the most difficult point in interventional treatment of airway obstruction." Zheng Rendao, "What method should be used to solve hypoxia and improve the oxygen supply to the heart?"
"EMCO?" Professor Rudolf Wagner suddenly said, "Oh my God, boss, can this thing work?!"
"ECMO is an expansion and extension of the scope of extracorporeal circulation technology. ECMO can provide effective respiratory and circulatory support to critically ill patients with respiratory and circulatory insufficiency who require external assistance." Zheng Rendao, "Don't focus on the patient in front of you. With his tumor, it’s easy to think of a solution.”